Medizinische Universität Graz - Research portal

Go directly to the nagivation.
Go directly to the content.

Navigation/Search

Researchers.
- Curriculum.
- Publications.
- Projects.
- Presentations.
Institutions.
Projects.
Publications.
Partners.
Sponsors.
Equipment.
Knowhow.
Fields of Research.

Perfler Bianca |

Presentations at scientific and public conferences

Bürger, M; Amor, M; Akhmetshina, A; Bianco, V; Weichhart, T; Perfler, B; Zebisch, A; Kratky, D Elucidating the Consequences of Loss of MMP12 in Lysosomal Acid Lipase Deficiency.
DK-MCD: 13th Scientific Retreat; SEP 26, 2023; Seggau, Austria. 2023. [Poster]

Bürger, M; Amor, M; Akhmetshina, A; Bianco, V; Perfler, B; Zebisch, A; Kratky, D Elucidating the Consequences of MMP12 Loss in Lysosomal Acid Lipase Deficiency
DK-MCD 12th Scientific Retreat; OCT 19, 2022; Schloss Seggau, Austria. 2022. [Poster]

Bürger, M; Amor, M; Akmetshina, A; Bianco, V; Perfler, B; Zebisch, A; Kratky, D Elucidating the Consequences of MMP12 Loss in Lysosomal Acid Lipase Deficiency
45th ELC Meeting ; AUG 8, 2022; Tutzing, GERMANY. 2022. [Oral Communication]

Telebar, F; Berg, JL; Perfler, B; Bramreiter, B; Caraffini, V; Prokesch, A; Geissler, K; Penz, T; Schuster, M; Reinisch, A; Wölfler, A; Sill, H; Zebisch, A; Co-occurrence of mutations modifying RAS and EZH2 inactivation in chronic myelomonocytic leukemia causes amplification of RAS-AKT signaling and increases the sensitivity to AKT inhibitors
Proceedings of the Annual Meeting of the Austrian Society of Haematology and Medical Oncology. memo 15 (Suppl 3), 37–67 (2022). . 2022; 15( ):S65--OeGHO- & AHOP-Frühjahrstagung 2022; April 8-10, 2022; Graz, Austria. [Oral Communication]
FullText

Berg, JL; Perfer, B; Hatzl, S; Reinisch, A; Pregartner, G; Klymiuk, I; Tierling, S; Geissler, G; Strobl, H; Berghold, A; Wölfer, A; Sill, H; Zebisch, A Aberrant expression of micro-RNA-125a plays a role in the pathogenesis and treatment of chronic myelomonocytic leukemia – Update
memo - Proceedings of the Annual Meeting of the Austrian Society of Haematology and Medical Oncology. 2021; 14: -Annual Meeting of the Austrian Society of Haematology and Medical Oncology; APR 8-10, 2021; Wien. [Poster]

Berg, JL; Perfler, B; Hatzl, S; Reinisch, A; Geissler, K; Strobl, H; Wölfler, A; Sill, H; Zebisch, A Expression of miR-125a is decreased in chronic myelomonocytic leukemia and of relevance for the treatment with 5-azacytidine
Proceedings of the Annual Meeting of the Austrian Society of Haematology and Medical Oncology, Magazine of European Medical Oncology. 2019; 12: 53--Annual Meeting of the Austrian Society of Haematology and Medical Oncology; APR 11-13, 2019; Linz, AUSTRIA. [Poster]

Hatzl, S; Ebner, S; Perfler, B; Quehenberger, F; Troppmair, J; Reinisch, A; Wölfler, A; Sill, H; Zebisch, A Increased expression of micro-RNA-23a causes resistance to cytarabine in acute myeloid leukemia.
Proceedings of the Annual Meeting of the Austrian Society of Haematology and Medical Oncology . 2018; Supplement 1/18: 26-26.-Annual Meeting of the Austrian Society for Hematology and Medical Oncology; APR, 19-21, 2018; Villach, AUSTRIA. [Oral Communication]

Caraffini, V; Geiger, O; Rosenberger, A; Hatzl, S; Perfler, P; Berg, JL; Lim, C; Strobl, H; Kashofer, K; Hoefler, G; Geissler, K; Kolch, W; Blyth, K; Athineos, D; Wölfler, A; Sill, H; Zebisch, A RAF kinase inhibitor protein is involved in the development of chronic myelomonocytic leukemia
memo - Magazine of European Medical Oncology. 2017; 10(2):21-21.-Annual Meeting of the Austrian Society of Haematology and Medical Oncology; APR 6-8, 2017; Bregenz, AUSTRIA. [Poster]